1,721,270 research outputs found
Epicardial coronary artery reactivity in patients with syndrome X: The role of increased adrenergic tone
No full textN/
Tackling cardiovascular health inequalities in European countries
No full textData on life expectancy at birth for both men and women show substantial differences between European countries. Countries in Eastern Europe have a much lower life expectancy compared with the rest of Europe. Considering the 2008–2017 averages, there was a difference of almost 9 years between the countries with the lowest and highest life expectancy: 73.9 years in Latvia compared to 82.7 years in Spain.1 Cardiovascular disease (CVD) is one of the leading causes of death in Europe where it is responsible for approximately 4 million deaths yearly (about 45% of the total deaths). Reducing the rates of CVD means increasing overall survival in Europe. Reducing cardiovascular health inequalities fundamentally means “increasing the power among people with the most limited possibilities of controlling and influencing their own life and society”
Behavioural risk factors and cardiovascular disease: are women at higher risk?
No full textNo abstract availabl
Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity
Full text linkAddressing sex differences and disparities in coronary heart disease (CHD) involves achieving both horizontal and vertical equity in healthcare. Horizontal equity in the context of CHD means that both men and women with comparable health statuses should have equal access to diagnosis, treatment, and management of CHD. To achieve this, it is crucial to promote awareness among the general public about the signs and symptoms of CHD in both sexes, so that both women and men may seek timely medical attention. Women often face inequity in the treatment of cardiovascular disease. Current guidelines do not differ based on sex, but their applications based on gender do differ. Vertical equity means tailoring healthcare to allow equitable care for all. Steps towards achieving this include developing treatment protocols and guidelines that consider the unique aspects of CHD in women. It also requires implementing guidelines equally, when there is not sex difference rather than inequities in application of guideline directed care
Alkaline phosphatase isoenzymes in liver cirrhosis
No full textThe study of a group of 114 hepatic patients allowed the authors to demonstrate the presence of an isophosphatase band, called ALP4, which can be of value as an index of evolutive cirrhosis. A certain correlation between the presence of this alkaline phosphatase isoenzyme in serum and histological evidence of moderate or extreme inflammatory response in liver biopsies was shown
Unstable angina and non Q-wave myocardial infarction. Early risk stratification: Role of silent ischemia and coronary morphology
No full textNo abstract availabl
- …
